News | December 16, 2009

Surgeons Highlight Benefits of Partial Breast Irradiation

December 17, 2009 - Partial breast irradiation "is an approach that may allow more patients to undergo breast-conserving therapy more quickly, at lower cost, and with less risk of long-term complications,” said The American College of Surgeons (ACS) in a consensus statement.*

In the document, the ACS emphasized the advantages of accelerated partial breast irradiation by delivering brachytherapy with open single-entry devices with multiple lumens. This technique includes SAVI radiation therapy provided at the Breast Clinic of Memphis. SAVI provides APBI, a shortened course of high-dose radiation therapy for early-stage breast cancer patients following lumpectomy surgery. The treatment is completed in just five days — compared to the six weeks of treatment, five days a week, required for traditional, external-beam radiation.

The device's multi-catheter design allows physicians to target radiation to the area that needs it most, minimizing exposure to healthy tissue. Precisely sculpted radiation is delivered from within the breast and targets the area where the cancer is most likely to recur.

In related news, Cianna Medical announced it has received ISO 13485:2003 certification for its quality management system for the design, development and manufacture of the SAVI breast brachytherapy applicator, which delivers targeted radiation therapy for the treatment of early-stage breast cancer.

The certification allows Cianna Medical to continue with the CE Mark registration process, which is required for sales within the European Economic Community. The CE Mark will apply to all four sizes of SAVI and the SAVI Prep Catheter.

The device's multi-catheter design enables physicians to direct radiation where it is needed most, while minimizing exposure to healthy structures, like the skin, chest wall or lungs. The ability to customize radiation based on patient-specific anatomy is said to help reduce complications typically associated with radiation therapy and allows physicians to offer the five-day treatment to more women.

The SAVI applicator received its 510(K) clearance from the U.S. Food & Drug Administration in July 2006.

*The ACS statement, titled “Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment,” was published in the October 2009 issue of the Journal of the American College of Surgeons.

For more information: www.facs.org and www.ciannamedical.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Pelvic Radiation Confirmed as Standard of Care for High-Risk, Early-Stage Endometrial Cancer
News | Brachytherapy Systems, Women's Healthcare | September 28, 2017
In a new phase III trial report, recurrence-free and overall survival rates for women with stage I-II high-risk...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...